Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanglaite for radiation mucositis in head and neck cancer
NCT03101514Phase 2Completed
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Jan 2017
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
A Phase 2 trial of kanglaite in Radiation mucositis (RIM), sponsored by The First Affiliated Hospital of Harbin Medical University. Started Jan 2017; status: completed.
02
Drugs
kanglaite
03
Conditions
Radiation mucositis (RIM)
Beyond the preview
Go deeper on NCT03101514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101514.